Upcoming Joint Webinar with the PSAD Study group - "Mental Health in Diabetes: A Cause for Concern"
- 2 days ago
- 4 min read
Updated: 1 day ago
The PSAD Study Group and EACLIPT are pleased to invite you to a joint webinar about "Mental Health in Diabetes – A Cause for Concern". This webinar brings together leading experts to explore the psychological dimensions of diabetes care. The session will feature insights into the emotional impact of diabetes, therapeutic approaches, and clinical assessment strategies. A live Q&A will follow the presentations.
🗓️ Date: October 28, 2025
🕓 Time: 16:30–17:30 CET
🔗 Register here: https://us02web.zoom.us/meeting/register/7j6mI-9eTIStoomlfiFISA
Chair & Introduction:
Prof. em. Frank J. Snoek (Netherlands) with a representative from EACLIPT
Speakers:
Prof. Dr. Bernhard Kulzer (Germany) – Diabetes, its treatment and psychological implications
Assoc. Prof. Katarzyna Maria Cyranka (Poland) – Psychological assessment and psychotherapy in diabetes
The PSAD Study Group is an international network of researchers, clinicians and people with diabetes who are focused on advancing our understanding of the psychological, social and behavioural aspects of diabetes.
You can find more info about them on their web page: https://www.psadgroup.org
👇 Below, you’ll find detailed bios of our speakers and chair, highlighting their expertise and contributions to psychodiabetology.
Prof. em. Frank J. Snoek
Frank Snoek, PhD is Professor emeritus and former head ofthe Department of Medical Psychology at the Amsterdam University Medical Center in Amsterdam, The Netherlands. He was trained as clinical psychologist and has a longstanding career in research and clinical practice in the field of ‘psychodiabetology’. He founded the Psycho Social Aspects of Diabetes (PSAD) study group under the auspices of the European Association for the Study of Diabetes (EASD). Prof. Snoek has published extensively on the topic of psychology in diabetes and is active member of national and international guidelines on psychosocial care for people living with diabetes. He is Specialty Chief Editor for Frontiers in Clinical Diabetes and Healthcare. He has received multiple awards, including the Richard Rubin Award from the American Diabetes Association (ADA) in 2019, and in 2020 HM the King of the Netherlands granted him the title of Knight in the Order of the Dutch Lion for his achievements in medical psychology and improving the lives of people with diabetes.
Prof. Dr. Bernhard Kulzer
Prof. Dr. Bernhard Kulzer is a qualified psychologist, licensed psychological psychotherapist and child and adolescent psychotherapist as well as a licensed diabetes psychologist DDG and psychodiabetologist. He is the managing director of the Research Institute Diabetes Academy Mergentheim (FIDAM) and diateam, the educational director of the advanced training for "Diabetes Educators DDG" and the director of the advanced training center for Psychodiabetologists in Bernkastel-Kues. He is a member of the diabetes center Bad Mergentheim, of the clinical psychology at the University of Bamberg, a lecturer at the University of Salzburg and, as project manager for mental aspects of diabetes, a member of the "German Diabetes Center" (DDZ).
Prof. Dr. Bernhard Kulzer is chairman of the association“Diabetes and Psychology e.V.” and the working group “Diabetes and Psychology, DDG”, he is board member of the working group “Prevention of Type 2 Diabetes, DDG”, member of the committees “Quality, Training and Further Education (QSW)" and of the "Commission Pharmacists in Diabetology (BAK / DDG)", on the scientific advisory board of the "Federal Center for Health Education", the diabetes advisory board at the Baden-Württemberg Ministry of Social Affairs and on the advisory board of diabetesDE.
He is the leader and member of several evidence-based guideline groups of the German Diabetes association (DDG): for the guidelines "NVL Training / Education", "Psychosocial and Diabetes", "Diabetes and Driving Ability", "Diabetes and Age" and "Prevention of Type 2 Diabetes". His main research focus is on psychological aspects of diabetes, psycho Immunology, person reported outcomes (PRO), diabetes and new technologies, development and evaluation of patient education and treatment programs and prevention of type 2 diabetes.
Assoc. Prof. Dr. Katarzyna Maria Cyranka
Prof. Dr. Katarzyna Maria Cyranka is a clinical psychologist, certified psychotherapist (Polish Psychiatric Association), and Jungian analyst (IAAP). She is Associate Professor at Jagiellonian University Medical College in Kraków, Poland, where she heads the Psychodiabetology Laboratory in the Department of Metabolic Diseases and the Adult Psychological Clinic at the University Hospital. She also coordinates the Psychodiabetology Team for patients with type 1 diabetes.
She is the initiator and director of Poland’s first national postgraduate program in psychodiabetology (launch 2026) and scientific editor of the first Polish textbook on psychodiabetology (PZWL, in preparation). She lectures in clinical psychology, psychotherapy, and psychiatry, and has completed fellowships at Amsterdam UMC, Sheba Medical Center, and LMU Munich.
Prof. Dr. Cyranka chairs the Psychodiabetology Section of thePolish Diabetes Association and serves on the boards of the Central European Diabetes Association (CEDA) and the Polish Psychiatric Association (Malopolska region). She is an active member of EASD, PSAD, IAAP, and the Society for Psychotherapy Research.
Her research focuses on psychological well-being and mental health in diabetes, especially type 1, as well as the psychological aspects of advanced diabetes technologies. She also works on integrated care models and psychotherapy of affective and anxiety disorders.
She is Managing Editor of Archives of Psychiatry and Psychotherapy, contributor to national clinical guidelines, and principal investigator of international projects including the implementation of MyDiaMate in Poland. She has received multiple awards, including the PSAD Mid Career Science Award (2025) and the Węgierka Award for achievements in psychodiabetology.